Sumitomo Dainippon Pharma (Japan)

Recent papers from Sumitomo Dainippon Pharma (Japan)

1. ATM inhibition enhances AAV-mediated targeted integration in pig zygotesCommunications Biology · 2026
2. Diagnostic prediction model for bacteraemia: an updated systematic review and meta-analysisBMC Infectious Diseases · 2026
3. A Derivatization Free HPLC–UV Method for Nitrite Quantification in Strongly Matrix‐Affected Pharmaceutical ExcipientsSeparation Science Plus · 2026
4. Neuroinflammation as molecular landscape of post-operative delirium revealed by live human brain multi-omics profilingMolecular Psychiatry · 2026
5. Associations between depressive symptoms and work productivity loss in patients with schizophrenia: an observational 48-week longitudinal studyBMC Psychiatry · 2026
6. Absolute ¹⁹F-qNMR Quantification of Fluorinated Pharmaceuticals: Fluorometholone, Flurbiprofen, and FlutamideChemical and Pharmaceutical Bulletin · 2026
7. A novel quantification method for unencapsulated doxorubicin in tissues: unlocking PK/PD and TK/TD insights for pegylated liposomal doxorubicinJournal of Liposome Research · 2026
8. A simple and practical approach for protein serial crystallography using grease matrix and large-area support filmJournal of Synchrotron Radiation · 2026
9. International implementation of ASIARS-net for AMR surveillance: Building on JANISJournal of Global Antimicrobial Resistance · 2026
10. Multi-Site Validation and Applicability Assessment of a Practical 3D Colony Formation Assay for Detecting Malignantly Transformed CellsCytotherapy · 2026
11. Stepwise Evaluation of Plasmid‐ and Adeno‐Associated Virus‐Based Knock‐In Using A Triple‐Reporter PlatformGenes to Cells · 2026
12. Sensory gating and auditory steady-state response analysis of eye contact deficit marmosets using a non-invasive scalp EEG systemJournal of Neurophysiology · 2026
13. Zuranolone mitigates delirium-like bispectral EEG changes, behavioral deficits, and neuroinflammation across surgical and inflammatory mouse models and age groups2026
14. DSP-2342, a novel 5-hydroxytryptamine 2A/7 receptor antagonist, has therapeutic potential for behavioral and psychological symptoms of dementiaJournal of Pharmacology and Experimental Therapeutics · 2026
15. Postoperative delirium in hip fracture patients linked to epigenetic alterations in inflammatory and immune pathways: a genome-wide DNA methylation studyTranslational Psychiatry · 2026
16. Partial Fluid-Air Exchange Enhances Submacular Injection of Retinal SheetsOphthalmic surgery, lasers & imaging retina · 2026
17. The Novel TRPV1 Agonist ST ‐6631 Improves Swallowing Function in Rat Models of Stroke‐Related Dysphagia and Demonstrates Pharmaceutical Advantage Over Capsaicin, by Exhibiting Minimal Pungent and Irritant PropertiesPharmacology Research & Perspectives · 2026
18. Development of an exon 27-skipping antisense oligonucleotide as a targeted therapy for refractory skin ulcers in Werner syndromeMolecular Therapy — Nucleic Acids · 2026
19. Pathway-specific regulation of the paraventricular thalamic nucleus in depressive-like behaviorScientific Reports · 2026
20. Antipsychotic-like effects of the selective Rho-kinase 2 inhibitor KD025 in genetic and pharmacological mouse models of schizophreniaMolecular Psychiatry · 2026